Meta-analysis and trial sequential analysis of Shenshao Capsules in treatment of angina pectoris in coronary heart disease
The efficacy and safety of Shenshao Capsules in combination with conventional western medicine for the treatment of angina pectoris in coronary heart disease were systematically evaluated.Computer search of seven databases,including CNKI,Wanfang,VIP,SinoMed,PubMed,EMbase,and Cochrane Library,was conducted to identify randomized controlled trial(RCT)on Shenshao Capsules for the treatment of angina pectoris in coronary heart disease up to December 2023.According to inclusion and exclusion criteria,articles were screened,and data was extracted.Cochrane bias risk assessment tool 2.0(RoB 2.0)was used to evaluate the quality of the included articles.Meta-analysis was performed by RevMan 5.4 and Stata/SE 15.1 software,and evidence quality was rated by the GRADE system.TSA 0.9.5.10 beta software was used for the trial sequential analysis(TSA).Twelve RCTs,with a total of 1 128 participants(567 in the experimental group and 561 in the control group),were included.Meta-analysis showed that Shenshao Capsules+conventional western medicine significantly improved clinical efficacy(RR=1.20,95%CI[1.15,1.26],P<0.000 01)and electrocardiogram efficacy(RR=1.16,95%CI[1.04,1.30],P=0.01),reduced the frequency of weekly angina pectoris attacks(MD=-2.85,95%CI[-5.27,-0.43],P=0.02),daily angina pectoris attacks(MD=-0.30,95%CI[-0.57,-0.03],P=0.03)and the duration of angina pectoris attacks(RR=-2.28,95%CI[-3.44,-1.12],P=0.000 1).There was no statistically significant difference in adverse reactions between the two groups(RR=1.33,95%CI[0.71,2.51],P=0.37).TSA indicated that the cumulative evidence for clinical efficacy exceeded the traditional boundary but did not exceed the TSA boundary,suggesting a potential false positive result.According to GRADE assessment,except for clinical efficacy,which was rated as low-quality evidence,the remaining outcomes were rated as very low-quality evidence.The results indicate that Shenshao Capsules+conventional western medicine may have certain advantages in improving clinical efficacy and electrocardiographic efficacy,reducing the frequency and duration of angina pectoris attacks.However,due to the limitations of this study,more rigorous and high-quality RCT is needed to validate its efficacy and safety.
NETL
NSTL
万方数据
